Production of Transgenic Rats

Transgenic Animal Technology: A Laboratory Handbook: Second Edition

Volumn , Issue , 2002, Pages 235-250

  Iannaccone, Philip ^a   Galat, Vasiliy ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84941102477     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-08-057480-6.50012-5     Document Type: Chapter

References (49)

1. Alhonen L., Parkkinen J.J., Keinanen T., Sinervirta R., Herzig K.H., Janne J. Activation of polyamine catabolism in transgenic rats induces acute pancreatitis. Proc. Natl. Acad. Sci. USA 2000, 97:8290-8295.
2. Bader M., Ganten D. Transgenic rats: tools to study the function of the renin-angiotensin system. Clin. Exp. Pharmacol. Physiol. Suppl. 1996, 3:S81-S87.
3. Bader M., Paul M., Ganten D. Transgenic animal models in hypertension. Biological Aspects of Disease: Contributions from Animal Models 1997, 165-200. Harwood Academic Publishers, Amsterdam. P.M. Iannaccone, D.G. Scarpelli (Eds.).
4. Bader M., Bohnemeier H., Zollmann F.S., Lockley-Jones O.E., Ganten D. Transgenic animals in cardiovascular disease research. Exp. Physiol. 2000, 85:713-731.
5. Bohlender J., Ganten D., Luft F.C. Rats transgenic for human renin and human angiotensinogen as a model for gestational hypertension. J. Am. Soc. Nephrol. 2000, 11:2056-2061.
6. Charreau B., Tesson L., Soulillou J.P., Pourcel C., Anegon I. Transgenesis in rats: technical aspects and models. Transgenic Res. 1996, 5:223-234.
7. Charreau B., Menoret S., Tesson L., Azimzadeh A., Audet M., Wolf P., Marquet R., Verbakel C., Ijzermans J., Cowan P., Pearse M., d'Apice A., Soulillou J.P., Anegon I. Protection against hyperacute xenograft rejection of transgenic rat hearts expressing human decay accelerating factor (DAF) transplanted into primates. Mol. Med. 1999, 5:617-630.
8. Chatot C.L., Ziomek C.A., Bavister B.D., Lewis J.L., Torres I. An improved culture medium supports development of random-bred one-cell mouse embryos in vitro. J. Reprod. Fertil. 1989, 86:679-688.
9. Chisholm J.W., Paterniti J.R., Dolphin P.J. Accumulation of cholestatic lipoproteins in ANIT-treated human apolipoprotein A-I transgenic rats is diminished through dose-dependent apolipoprotein A-I activation of LCAT. Biochim. Biophys. Acta 2000, 1487:145-154.
10. Cowley A.W., Stoll M., Greene A.S., Kaldunski M.L., Roman R.J., Tonellato P.J., Schork N.J., Dumas P., Jacob H.J. Genetically defined risk of salt sensitivity in an intercross of Brown Norway and Dahl S rats. Physiol. Genomics 2000, 2:107-115.
11. Fitchev P., Taborn G., Garton R., Iannaccone P. Nuclear transfer in the rat: potential access to the germline. Transplant. Proc. 1999, 31:1525-1530.
12. Gomez-Angelats M., Teeguarden J.G., Dragan Y.P., Pitot H.C. Mutational analysis of three tumor suppressor genes in two models of rat hepatocarcinogenesis. Mol. Carcinog. 1999, 25:157-163.
13. Haas M.J., Pitot H.C. Characterization of rare p53 mutants from carcinogen-treated albumin-simian virus 40 T-antigen transgenic rats. Mol. Carcinog. 1998, 21:128-134.
14. Haas M.J., Dragan Y.P., Hikita H., Shimel R., Takimoto K., Heath S., Vaughan J., Pitot H.C. Transgene expression and repression in transgenic rats bearing the phosphoenolpyruvate carboxykinase-simian virus 40 T antigen or the phosphoenolpyruvate carboxykinase-transforming growth factor-alpha constructs. Am. J. Pathol. 1999, 155:183-192.
15. Haas M.J., Sattler C.A., Dragan Y.P., Gast W.L., Pitot H.C. Multiple polypeptide hormone expression in pancreatic islet cell carcinomas derived from phosphoenolpyruvate carboxykinase-SV40 T antigen transgenic rats. Pancreas 2000, 20:206-214.
16. Hamilton G.S., Armstrong D.T. The superovulation of synchronous adult rats using follicle-stimulating hormone delivered by continuous infusion. Biol. Reprod. 1991, 44:851-856.
17. Hammer R.E., Maika S.D., Richardson J.A., Tang J.P., Taurog J.D. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell 1990, 63:1099-1112.
18. Hully J.R., Su Y., Lohse J.K., Griep A.E., Sattler C.A., Haas M.J., Dragan Y., Peterson J., Neveu M., Pitot H.C. Transgenic hepatocarcinogenesis in the rat. Am. J. Pathol. 1994, 145:386-397.
19. Iannaccone P.M. Fractal geometry in mosaic organs: a new interpretation of mosaic pattern. FASEB J. 1990, 4:1508-1512.
20. Iannaccone P.M., Taborn G., Garton R. Preimplantation and postimplantation development of rat embryos cloned with cumulus cells and fibroblasts. Zygote. 2001, 9:135-143.
21. Jacob H.J. Functional genomics and rat models. Genome Res. 1999, 9:1013-1016.
22. Khokha M.K., Landini G., Iannaccone P.M. Fractal geometry in rat chimeras demonstrates that a repetitive cell division program may generate liver parenchyma. Dev. Biol. 1994, 165:545-555.
23. Lois C., Hong E.J., Pease S., Brown E.J., Baltimore D. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 2002, 295:868-872.
24. Lundin P.D., Ekstrom G., Erlansson M., Lundin S., Westrom B.R. Intestinal inflammation and barrier function in HLA-B27/beta 2-microglobulin transgenic rats. Scand. J. Gastroenterol. 1997, 32:700-705.
25. Mayer C., Klein R.G., Wesch H., Schmezer P. Nickel subsulfide is genotoxic in vitro but shows no mutagenic potential in respiratory tract tissues of BigBlue rats and Muta Mouse mice in vivo after inhalation. Mutat. Res. 1998, 420:85-98.
26. Mervaala E., Muller D.N., Park J.K., Dechend R., Schmidt F., Fiebeler A., Bieringer M., Breu V., Ganten D., Haller H., Luft F.C. Cyclosporin A protects against angiotensin II-induced end-organ damage in double transgenic rats harboring human renin and angiotensinogen genes. Hypertension 2000, 35:360-366.
27. Mervaala E., Muller D.N., Schmidt F., Park J.K., Gross V., Bader M., Breu V., Ganten D., Haller H., Luft F.C. Blood-pressure-independent effects in rats with human renin and angiotensinogen genes. Hypertension 2000, 35:587-594.
28. Miyoshi K., Niwa K. Stage-specific requirement of phosphate for development of rat 1-cell embryos in a chemically defined medium. Zygote 1997, 5:67-73.
29. Miyoshi K., Kono T., Niwa K. Stage-dependent development of rat 1-cell embryos in a chemically defined medium after fertilization in vivo and in vitro. Biol. Reprod. 1997, 56:180-185.
30. Mukumoto S., Mori K., Ishikawa H. Efficient induction of superovulation in adult rats by PMSG and hCG. Exp. Anim. 1995, 44:111-118.
31. Mullins J.J., Mullins L.J. Transgenesis in nonmurine species. Hypertension 1993, 22:630-633.
32. Mullins L.J., Mullins J.J. Transgenesis in the rat and larger mammals. J. Clin. Invest. 1996, 97:1557-1560.
33. Ng Y.K., Iannaccone P.M. Fractal geometry of mosaic pattern demonstrates liver regeneration is a self-similar process. Dev. Biol. 1992, 151:419-430.
34. Onderdonk A.B., Richardson J.A., Hammer R.E., Taurog J.D. Correlation of cecal microflora of HLA-B27 transgenic rats with inflammatory bowel disease. Infect. Immun. 1998, 66:6022-6023.
35. Quinn P., Barros C., Whittingham D.G. Preservation of hamster oocytes to assay the fertilizing capacity of human spermatozoa. J. Reprod. Fertil. 1982, 66:161-168.
36. Schmezer P., Eckert C. Induction of mutations in transgenic animal models: BigBlue and Muta Mouse. IARC Sci. Publ. 1999, 146:367-394.
37. Simmons W.A., Leong L.Y., Satumtira N., Butcher G.W., Howard J.C., Richardson J.A., Slaughter C.A., Hammer R.E., Taurog J.D. Rat MHC-linked peptide transporter alleles strongly influence peptide binding by HLA-B27 but not B27-associated inflammatory disease. J. Immunol. 1996, 156:1661-1667.
38. Sinn P.L., Sigmund C.D. Transgenic models as tools for studying the regulation of human renin expression. Regul. Pept. 2000, 86:77-82.
39. Springate J.E., Feld L.G., Ganten D. Enalapril and renal function in hypertensive rats transgenic for mouse renin gene. Hypertension 1997, 30:868-872.
40. Steen R.G., Kwitek-Black A.E., Glenn C., Gullings-Handley J., Van Etten W., Atkinson O.S., Appel D., Twigger S., Muir M., Mull T., Granados M., Kissebah M., Russo K., Crane R., Popp M., Peden M., Matise T., Brown D.M., Lu J., Kingsmore S., Tonellato P.J., Rozen S., Slonim D., Young P., Jacob H.J., et al. A high-density integrated genetic linkage and radiation hybrid map of the laboratory rat. Genome Res. 1999, 9:AP1-AP8. insert.
41. Stoll M., Kwitek-Black A.E., Cowley A.W., Harris E.L., Harrap S.B., Krieger J.E., Printz M.P., Provoost A.P., Sassard J., Jacob H.J. New target regions for human hypertension via comparative genomics. Genome Res. 2000, 10:473-482.
42. Sturm K., Tam P.L. Isolation and culture of whole postimplantation embryos and germ layer derivatives. Guide to Techniques in Mouse Development: Methods in Enzymology 1993, 225:164-190. Academic Press, San Diego. P. Wasserman, M. De Pamphilis (Eds.).
43. Takahashi R., Hirabayashi M., Ueda M. Production of transgenic rats using cryopreserved pronuclear-stage zygotes. Transgenic Res. 1999, 8:397-400.
44. Taurog J.D., Hammer R.E. Experimental spondyloarthropathy in HLA-B27 transgenic rats. Clin. Rheumatol. 1996, 15(suppl. 1):22-27.
45. Taurog J.D., Maika S.D., Satumtira N., Dorris M.L., McLean I.L., Yanagisawa H., Sayad A., Stagg A.J., Fox G.M., Le O'Brien A., Rehman M., Zhou M., Weiner A.L., Splawski J.B., Richardson J.A., Hammer R.E. Inflammatory disease in HLA-B27 transgenic rats. Immunol. Rev. 1999, 169:209-223.
46. Weinberg W.C., Iannaccone P.M. Clonality of preneoplastic liver lesions: histological analysis in chimeric rats. J. Cell. Sci. 1988, 89:423-431.
47. Weinberg W.C., Deamant F.D., Iannaccone P.M. Patterns of expression of class I antigens in the tissues of congenic strains of rat. Hybridoma 1985, 4:27-36.
48. Weinberg W.C., Berkwits L., Iannaccone P.M. The clonal nature of carcinogen-induced altered foci of gamma-glutamyl transpeptidase expression in rat liver. Carcinogenesis 1987, 8:565-570.
49. Zhou M., Sayad A., Simmons W.A., Jones R.C., Maika S.D., Satumtira N., Dorris M.L., Gaskell S.J., Bordoli R.S., Sartor R.B., Slaughter C.A., Richardson J.A., Hammer R.E., Taurog J.D. The specificity of peptides bound to human histocompatibility leukocyte antigen (HLA)-B27 influences the prevalence of arthritis in HLA-B27 transgenic rats. J. Exp. Med. 1998, 188:877-886.